|
시장보고서
상품코드
2126536
심혈관 정보 시스템 : 시장 인사이트, 경쟁 구도 및 시장 예측(2034년)Cardiovascular Information System - Market Insights, Competitive Landscape, and Market Forecast - 2034 |
||||||
DelveInsight
개요 :
- 심혈관 정보 시스템 시장은 2025년에 13억 5,000만 달러로 추산되며, 2034년까지 29억 8,000만 달러에 달할 것으로 전망됩니다. 이러한 성장 요인으로는 전 세계 심혈관 질환 부담의 증가, 심장 영상 진단 및 보고서 작성 워크플로우의 디지털화 및 통합 가속화, 그리고 클라우드 기반 AI 통합 심혈관 IT 플랫폼의 도입 확대 등이 꼽힙니다.
- 전 세계 심혈관 정보 시스템 시장은 2026-2034년까지의 예측 기간 중 연평균 성장률(CAGR) 9.2%로 성장하고 있습니다.
- 시스템 유형별로는 2025년에 심혈관 정보 시스템(CVIS) 부문이 55%의 점유율을 차지하며 심혈관 정보 시스템 시장을 주도했습니다.
- 구성 요소별로는 2025년에 소프트웨어 부문이 51%의 점유율을 차지하며 심혈관 정보 시스템 시장을 주도했습니다.
- 배포 방식별로는 2025년에 온프레미스 부문이 46%의 점유율을 차지하며 심혈관 정보 시스템 시장을 주도했습니다.
- 최종사용자별로는 2025년에 병원 부문이 58%의 점유율을 차지하며 심혈관 정보 시스템 시장을 주도했습니다.
- 북미는 2025년에 46%의 점유율로 전 세계 심혈관 정보 시스템 시장의 매출을 주도하며, 전 세계에서 가장 높은 지역 시장 점유율을 차지했습니다.
심혈관 정보 시스템(CVIS)이란 병원, 진단 센터 및 심장병 클리닉이 심장 초음파 검사, 심장 카테터 검사, 전기생리학 검사, 핵의학 심장 검사 및 혈관 검사에 걸친 심혈관 영상 및 시술 데이터를 수집, 저장, 관리, 보고하기 위해 사용하는 임상 및 운영 전용 소프트웨어 플랫폼입니다. CVIS와 병행하여, 심혈관 영상 아카이브 및 통신 시스템(CPACS)은 대개 보다 광범위한 기업용 영상 전략이나 벤더 중립 아카이브(NVA)의 일환으로, 심장 영상 검사 데이터의 저장, 검색 및 전달을 관리합니다. 심혈과에서는 여러 모달리티에 걸쳐 다양한 파형, 정지 영상 및 시네 루프 데이터가 대량으로 생성되므로, 대부분의 의료 제공자는 구조화된 보고서, 혈행동태 모니터링,및 품질 레지스트리를 지원하기 위해 범용 방사선과용 PACS가 아닌 전용 심혈관 IT 플랫폼에 의존하고 있습니다. 이 시장은 시스템 유형별(CVIS 및 CPACS), 구성 요소별(소프트웨어 및 서비스), 도입 형태별(온프레미스, 클라우드 기반, 하이브리드 모델), 그리고 최종사용자별(규모가 다른 병원, 진단 센터, 전문 심혈관 센터, 기타 의료 현장)로 분류됩니다. 전 세계 심혈관 질환 유병률의 증가,클라우드 호스팅 방식이자 AI를 지원하는 심혈관 플랫폼으로의 전환, 전자건강기록(EHR)과의 상호운용성에 대한 요구 증가, 그리고 방사선과와 심혈과 영상 진단을 통합된 기업 아카이브 하에 통합하려는 움직임에 힘입어, 심혈관 정보 시스템은 현대 심혈관 의료 서비스 라인을 지원하는 필수적인 인프라로 자리 잡았습니다.
심혈관 정보 시스템 시장의 주요 성장 동인
- 전 세계 심혈관 질환 유병률의 증가로 인해 심장 영상 진단, 시술 건수, 그리고 병원 및 전문 심장병 센터 전반에서 이러한 데이터를 관리하는 정보 시스템에 대한 수요가 지속적으로 증가하고 있습니다.
- 각 심혈관 정보 시스템 벤더들은 클라우드 호스팅형 및 SaaS(Software-as-a-Service) 방식로의 전환을 가속화하고 있으며, 그 일례로 필립스가 2025년 11월, 자사의 HealthSuite 디지털 플랫폼을 통해 제공되는 클라우드 지원 ‘Cardiovascular Workspace’에 대해FDA의 510(k) 승인을 획득한 것을 예로 들 수 있습니다.
- GE 헬스케어의 ‘Centricity Cardio Enterprise’나 필립스의 ‘IntelliSpace Cardiovascular’ 등, 인공지능(AI)을 심혈관 보고서 작성 및 분석에 통합함으로써 진단 정확도가 향상되어 플랫폼 도입이 가속화되고 있습니다.
- 심혈관 정보 시스템, 전자 건강 기록, 카테터실 및 혈행동태 모니터링 시스템 간의 상호 운용성에 대한 수요가 증가함에 따라 특히 북미 지역의 HITECH 및 HIPAA 준수 규제 기준 하에서 통합 플랫폼 도입이 확대되고 있습니다.
- 의료 기관에서는 데이터 사일로를 해소하고 임상의의 워크플로우를 효율화하기 위해, 방사선과 및 심혈관과 영상 진단을 단일 기업 영상 아카이브 및 벤더 중립 아카이브(NVA) 전략 하에 통합하려는 움직임이 점점 더 확산되고 있습니다.
- 원격 모니터링 및 원격의료와의 통합 확대(여기에는 원격 심혈관 모니터링을 강화하기 위해 필립스가 2026년 1월에 원격의료 제공업체와 체결한 제휴도 포함됩니다)에 따라 심혈관 정보 시스템의 임상적 적용 범위가 넓어지고 있습니다.
- 기존의 온프레미스형 심혈관 시스템을 구조화된 보고서 기능과 분석 기능을 갖춘 최신 플랫폼으로 대체하는 움직임에 따라 확립된 병원 네트워크 전반에 걸쳐 꾸준한 갱신 및 업그레이드 주기가 형성되고 있습니다.
- 질병 부담의 증가, 클라우드 전환, AI를 활용한 분석, 그리고 기업 이미징의 통합과 같은 요인들이 맞물려, 2034년까지 시장은 안정적인 한 자릿수 후반에서 두 자릿수 초반의 성장세를 유지할 것으로 예상됩니다.
심혈관 정보 시스템 시장의 성장에 기여하는 요인
시장 촉진요인
전 세계 심혈관 질환 부담의 증가
심혈관 정보 시스템 시장의 가장 큰 촉진요인은 전 세계에서 계속 증가하는 심혈관 질환의 부담입니다. 심혈관 질환은 여전히 전 세계 사망 원인 1위를 차지하고 있습니다. 순환기내과에서 심장 초음파 검사, 심장 카테터 검사, 전기생리학적 검사, 핵의학 검사의 실시 건수가 증가함에 따라 병원에서는 이러한 다양한 영상 데이터와 혈행동태 데이터를 대규모로 수집·구조화·보고할 수 있는 전용 플랫폼이 필요해지고 있습니다. 관상동맥 질환, 심부전, 구조적 심장 질환에 대한 중재적 치료가 증가함에 따라 기록 및 보존되어 의료진 간에 공유되어야 하는 심장 진료 건수도 확대되고 있습니다. 심혈관 질환은 고령자에게 특히 큰 영향을 미치고 있으며, 또한 대부분의 지역에서 평균 수명이 계속 늘어나고 있는 만큼, 심혈관 영상 진단 및 모니터링이 필요한 환자층은 앞으로도 계속 확대될 것으로 예상되어, 2034년까지 심혈관 정보 시스템에 대한 지속적인 수요를 지원하는 요인이 될 것입니다.
클라우드 호스팅형 및 SaaS형 심혈관 플랫폼으로의 전환 가속화
클라우드 호스팅형 및 SaaS(Software-as-a-Service)형으로의 구조적 전환이 경쟁 구도를 재편하고 있습니다. 2025년 11월, 필립스는 HealthSuite 디지털 플랫폼을 통해 제공되는 ‘Cardiovascular Workspace’의 클라우드 지원 버전에 대해 FDA의 510(k) 승인을 획득했습니다. 이는 원격 영상 판독, 확장 가능한 분석, 그리고 인공지능(AI) 툴의 신속한 도입을 지원하는 것입니다. 이에 이어 GE 헬스케어는 2025년 12월, 시설 간 데이터 통합을 촉진하도록 설계된 클라우드 기반 심혈관 정보 시스템을 발표했습니다. 클라우드 배포을 통해 온프레미스 인프라의 부담이 경감되고 재해 복구 능력이 향상될 뿐만 아니라, 다중 거점 의료 시스템에서 지역적으로 분산된 시설 간 심혈관 워크플로우를 표준화할 수 있게 됩니다. 따라서 특히 레거시 시스템의 현대화를 목표로 하는 중규모 및 지역 병원 네트워크 사이에서 클라우드 배포는 점점 더 선호되는 도입 모델이 되고 있습니다.
시장 제약 요인
호조세를 보이는 성장 추세에도 불구하고 심혈관 정보 시스템 시장은 몇 가지 중대한 제약에 직면해 있습니다. 플랫폼 도입, 구현 및 지속적인 유지보수에 드는 높은 비용은 소규모 병원, 지역 의료 시스템 및 가격에 민감한 신흥 시장의 의료 서비스 제공자에게 여전히 큰 장벽이 되고 있으며, 이는 종종 판매 주기의 장기화나 도입 지연을 초래합니다. 통합의 복잡성도 큰 과제입니다. 심혈관 정보 시스템은 서로 다른 제조업체에서 생산한 수많은 카테터실용 장비, 심장 초음파 검사 장치, 전기생리학용 장비 및 혈행동태 모니터링 장치와 상호 운용될 수 있어야 하며, 기존 기법 간의 데이터 표준 불일치는 도입을 복잡하게 만들고 구현 기간을 연장하는 요인이 됩니다. 복잡한 심혈관 정보 시스템의 도입을 관리할 수 있는 숙련된 의료 IT 인력 부족 또한 특히 주요 대학병원을 제외한 곳에서는 사업 규모 확장을 제약하는 요인이 되고 있습니다. 데이터 보안 및 상호 운용성에 대한 우려는 여전히 남아 있으며, 레거시 PACS 소프트웨어에서 드러난 사이버 보안 취약성으로 인해 지속적인 패치 적용과 거버넌스가 필요하다는 점도 이러한 우려를 더욱 강화하고 있습니다. 신흥 시장의 보상 제도 분절화와 디지털 헬스 인프라의 불균일성은 북미 및 유럽 이외 지역에서의 도입을 지연시키고 있습니다. 한편, 정착된 레거시 시스템에서 전환하는 데 따르는 전환 비용과 워크플로우의 혼란은 새로운 플랫폼이 임상적·운영상의 명확한 이점을 제공하더라도 도입을 정체시키고 있습니다. 이러한 비용, 통합, 인력, 보안, 인프라와 관련된 장벽들이 복합적으로 작용하여, 질병 부담의 증가, 클라우드 전환, AI 도입과 같은 근본적인 촉진요인들이 여전히 견고함에도 불구하고 성장 속도를 둔화시키고 있습니다.
자주 묻는 질문
목차
제1장 심혈관 정보 시스템 시장 : 서론
제2장 심혈관 정보 시스템 시장 : 개요
제3장 심혈관 정보 시스템 시장 : 주요 요인 분석
제4장 AI, 지정학, 무역 및 경제의 동향
제5장 규제 분석
제6장 Porter's Five Forces 분석
제7장 심혈관 정보 시스템 시장 : 평가
제8장 심혈관 정보 시스템 시장 : 경쟁 구도
제9장 심혈관 정보 시스템 시장 : 스타트업 자금조달 및 투자 동향
제10장 심혈관 정보 시스템 시장 : 기업 개요 및 제품 개요
제11장 KOL의 견해
제12장 프로젝트 어프로치
제13장 DelveInsight 소개
제14장 면책사항 및 문의
KSA 26.09.14Cardiovascular Information System Market Summary
Overview:
- The Cardiovascular Information System market is estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.98 billion by 2034. Growth is anchored in the rising global burden of cardiovascular disease, accelerating digitization and consolidation of cardiology imaging and reporting workflows, and growing adoption of cloud-enabled, AI-integrated cardiovascular IT platforms.
- The global Cardiovascular Information System market is growing at a CAGR of 9.2% during the forecast period from 2026 to 2034.
- By system type, the Cardiovascular Information System (CVIS) segment dominated the Cardiovascular Information System market with a 55% share in 2025.
- By component, the software segment dominated the Cardiovascular Information System market with a 51% share in 2025.
- By deployment, the on-premises segment dominated the Cardiovascular Information System market with a 46% share in 2025.
- By end user, the hospitals segment dominated the Cardiovascular Information System market with a 58% share in 2025.
- North America dominated the global Cardiovascular Information System market revenue with a 46% share in 2025, representing the highest regional market share globally.
A cardiovascular information system (CVIS) is a specialized clinical and operational software platform used by hospitals, diagnostic centers, and cardiology practices to capture, store, manage, and report cardiovascular imaging and procedural data across echocardiography, cardiac catheterization, electrophysiology, nuclear cardiology, and vascular studies. Alongside CVIS, cardiovascular picture archiving and communication systems (CPACS) manage the storage, retrieval, and distribution of cardiac imaging studies, often within a broader enterprise imaging or vendor-neutral archive strategy. Because cardiology departments generate high volumes of heterogeneous waveform, still-image, and cine-loop data across multiple modalities, most healthcare providers rely on dedicated cardiovascular IT platforms rather than generic radiology PACS to support structured reporting, hemodynamic monitoring, and quality registries. The market is organized by system type across CVIS and CPACS; by component across software and services; by deployment across on-premises, cloud-based, and hybrid models; and by end user across hospitals of varying size, diagnostic centers, specialty cardiology centers, and other care settings. Driven by the rising global prevalence of cardiovascular disease, the shift toward cloud-hosted and AI-enabled cardiology platforms, growing interoperability requirements with electronic health records, and the consolidation of radiology and cardiology imaging under unified enterprise archives, cardiovascular information systems have become essential infrastructure underpinning modern cardiology service lines.
Cardiovascular Information System Market Key Growth Drivers
- The rising global prevalence of cardiovascular disease is driving sustained demand for cardiology imaging, procedural volumes, and the information systems that manage this data across hospitals and specialty cardiology centers.
- Cardiovascular information system vendors are accelerating the shift to cloud-hosted and software-as-a-service deployment, exemplified by Philips' November 2025 FDA 510(k) clearance for a cloud-enabled Cardiovascular Workspace delivered through its HealthSuite digital platform.
- The integration of artificial intelligence into cardiology reporting and analytics, including GE HealthCare's Centricity Cardio Enterprise and Philips' IntelliSpace Cardiovascular, is improving diagnostic accuracy and accelerating platform adoption.
- Growing demand for interoperability between cardiovascular information systems, electronic health records, and cath lab and hemodynamic monitoring systems is expanding integrated platform adoption, particularly under HITECH and HIPAA-aligned regulatory standards in North America.
- Health systems are increasingly consolidating radiology and cardiology imaging under a single enterprise imaging archive and vendor-neutral storage strategy to reduce data silos and streamline clinician workflows.
- Expanding remote monitoring and telehealth integration, including Philips' January 2026 partnership with a telehealth provider to enhance remote cardiovascular monitoring, is broadening the clinical scope of cardiovascular information systems.
- The replacement of legacy, on-premises cardiology systems with modern, structured-reporting and analytics-enabled platforms is generating a steady replacement and upgrade cycle across established hospital networks.
- The convergence of rising disease burden, cloud migration, AI-enabled analytics, and enterprise imaging consolidation is expected to sustain steady, high-single-digit-to-low-double-digit growth in the market through 2034.
Key Companies in Cardiovascular Information System Market
The competitive landscape is led by the following active manufacturers:
- GE HealthCare
- Koninklijke Philips N.V.
- Siemens Healthineers AG
- Fujifilm Holdings Corporation
- Agfa HealthCare
- INFINITT Healthcare Co., Ltd.
- Sectra AB
- Canon Medical Systems Corporation
- Merative L.P.
- Digisonics, Inc.
Factors Contributing to the Growth of the Cardiovascular Information System Market
Market Drivers
Rising Global Burden of Cardiovascular Disease
The single most powerful driver of the Cardiovascular Information System market is the escalating global burden of cardiovascular disease, which remains the leading cause of death worldwide. As cardiology departments perform growing volumes of echocardiography, cardiac catheterization, electrophysiology, and nuclear cardiology procedures, hospitals require dedicated platforms capable of capturing, structuring, and reporting this heterogeneous imaging and hemodynamic data at scale. Rising rates of coronary artery disease, heart failure, and structural heart interventions are expanding the number of cardiology encounters that must be documented, archived, and shared across care teams. Because cardiovascular disease disproportionately affects aging populations, and life expectancy continues to rise across most regions, the underlying patient population requiring cardiology imaging and monitoring is expected to keep expanding, anchoring durable demand for cardiovascular information systems through 2034.
Accelerating Shift to Cloud-Hosted and SaaS Cardiovascular Platforms
A structural shift toward cloud-hosted and software-as-a-service deployment is reshaping the competitive landscape. In November 2025, Philips received FDA 510(k) clearance for a cloud-enabled release of its Cardiovascular Workspace, delivered through the HealthSuite digital platform to support remote reading, scalable analytics, and faster adoption of artificial intelligence tools. GE HealthCare followed with a cloud-based cardiovascular information system in December 2025 designed to facilitate data integration across facilities. Cloud deployment reduces on-premises infrastructure burden, improves disaster recovery, and enables multi-site health systems to standardize cardiology workflows across geographically distributed facilities, making it an increasingly preferred deployment model, particularly among mid-sized and community hospital networks seeking to modernize legacy systems.
Market Restraints
Despite favorable growth dynamics, the Cardiovascular Information System market faces several material constraints. The high cost of platform acquisition, implementation, and ongoing maintenance remains a significant barrier for smaller hospitals, community health systems, and providers in price-sensitive emerging markets, often lengthening sales cycles and slowing adoption. Integration complexity is substantial, as cardiovascular information systems must interoperate with numerous cath lab, echocardiography, electrophysiology, and hemodynamic monitoring devices from different manufacturers, and inconsistent data standards across legacy modalities can complicate deployment and increase implementation timelines. A shortage of skilled health IT personnel capable of managing complex cardiology informatics deployments constrains scale-up, particularly outside major academic medical centers. Data security and interoperability concerns persist, reinforced by disclosed cybersecurity vulnerabilities in legacy PACS software that require ongoing patching and governance. Fragmented reimbursement and uneven digital health infrastructure across emerging markets slow adoption outside North America and Europe, while switching costs and workflow disruption associated with migrating from entrenched legacy systems create inertia even where newer platforms offer clear clinical and operational advantages. Together, these cost, integration, workforce, security, and infrastructure barriers temper the pace of growth, even as the underlying drivers of rising disease burden, cloud migration, and AI adoption remain firmly intact.
Cardiovascular Information System Market Segment Analysis
The cardiovascular information system market by system type (cardiovascular information system (cvis), cardiovascular picture archiving and communication system (cpacs)), component (software, services), deployment (on-premise, cloud-based, hybrid), end user (hospitals, diagnostic centers, specialty cardiology centers, others), and geography (North America, Europe, Asia-Pacific, and Rest of World).
By System Type
Dominant Subsegment: Cardiovascular Information System (CVIS).
The Cardiovascular Information System (CVIS) segment accounted for 55% of the Cardiovascular Information System market in 2025. CVIS is the leading system type because it functions as the clinical backbone of the cardiology department, capturing structured reporting, hemodynamic data, and procedural documentation across echocardiography, cardiac catheterization, electrophysiology, and nuclear cardiology in a single relational database. Its central role in quality registries, structured reporting, and clinical decision support makes it the platform of choice for hospitals seeking to standardize cardiology workflows and satisfy regulatory reporting requirements. Cardiovascular picture archiving and communication systems (CPACS), which focus primarily on image storage, retrieval, and distribution, are growing steadily as health systems expand cardiac imaging volumes and increasingly integrate cardiology data into enterprise-wide vendor-neutral archives. However, the breadth of clinical functionality, deeper EHR integration, and central role in cardiology quality reporting secure CVIS's leadership across the forecast period.
By Component
Dominant Subsegment: Software.
The software segment accounted for 51% of the Cardiovascular Information System market in 2025. Software is the leading component because it delivers the core structured reporting, image management, analytics, and interoperability functionality that defines platform value, and because ongoing software licensing, upgrades, and AI-enabled modules represent a recurring, high-margin revenue stream for vendors. Health systems are increasingly investing in advanced software capabilities, including AI-assisted measurement, native reporting editors, and cloud-native architectures, to differentiate clinical workflows and improve reporting turnaround time. The services segment, spanning implementation, training, technical support, and managed hosting, is growing at a faster pace as more health systems adopt cloud-based and software-as-a-service deployment models that shift ongoing platform management to the vendor. Nonetheless, the foundational role and recurring monetization of software keep it the dominant component through the forecast period.
Cardiovascular Information System Market Region Analysis
Dominant Region: North America
North America accounted for 46% of the global Cardiovascular Information System market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a mature cardiology IT ecosystem, high cardiovascular disease prevalence, deep electronic health record penetration, and clear FDA regulatory pathways for cloud-enabled and AI-integrated platforms, particularly in the United States. North America hosts the largest concentration of enterprise cardiology imaging deployments and the highest density of Best in KLAS-ranked vendors, including Sectra, INFINITT, Agfa HealthCare, and Merge by Merative, reflecting strong platform maturity and customer satisfaction. Regulatory frameworks under HITECH and HIPAA reinforce demand for interoperable, secure cardiovascular information systems, while major vendors including GE HealthCare and Philips continue to launch cloud-enabled and AI-powered platforms first in the region. Strong reimbursement structures, high hospital IT budgets, and rapid adoption of cloud and AI-enabled cardiology platforms anchor the region's continued leadership across the forecast period.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the Cardiovascular Information System market. The region's elevated CAGR is driven by rising cardiovascular disease incidence, rapid hospital infrastructure development, and growing healthcare IT investment across China, Japan, India, South Korea, and Australia. China and India are expanding hospital networks and digitizing cardiology departments that previously relied on paper-based or fragmented systems; Japan is upgrading legacy cardiology IT infrastructure toward cloud and AI-enabled platforms, and South Korea benefits from strong domestic vendors such as INFINITT Healthcare extending regional reach. Government healthcare digitization initiatives, expanding cardiology procedure volumes, and growing private hospital investment are accelerating adoption, while international vendors are increasingly localizing cloud-hosted offerings to meet regional data residency requirements. The combination of high disease burden, infrastructure build-out, and healthcare IT modernization positions Asia-Pacific as the principal source of incremental growth over the forecast period.
Regional Commentary
North America
North America accounted for 46% of the global Cardiovascular Information System market revenue in 2025. The United States dominates on the strength of its mature cardiology IT ecosystem, high cardiovascular disease burden, FDA regulatory clarity for cloud-enabled and AI-integrated platforms, and the concentration of leading, highly rated vendors, while Canada contributes steady growth through cloud enterprise imaging adoption, exemplified by Sectra One Cloud's selection by Hennick-Humber Hospital in 2026.
Europe
Europe is a large and advanced regional market, supported by established enterprise imaging vendors such as Sectra and Agfa HealthCare, strong regulatory frameworks for medical device software, and growing consolidation of radiology and cardiology imaging under unified vendor-neutral archives. Sectra's continued Best in KLAS recognition across Northern Europe, Southern Europe, and the DACH region, together with its 2026 acquisition of AI diagnostics company Oxipit, reinforces the region's role in advancing autonomous AI-enabled cardiovascular imaging across Germany, the United Kingdom, France, Italy, and Spain.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by rising cardiovascular disease incidence, rapid hospital infrastructure development, and growing healthcare IT investment across China, Japan, India, South Korea, and Australia. Regional digitization initiatives, expanding private hospital networks, and the presence of strong domestic vendors such as INFINITT Healthcare are accelerating cardiovascular information system adoption and cloud migration across the region.
Rest of World
The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding hospital infrastructure, rising demand for structured cardiology reporting and quality registries, and gradual alignment of health IT procurement with international interoperability standards are broadening access, while international vendors increasingly offer cloud-hosted and managed-service models suited to markets with limited on-premise IT capacity.
Cardiovascular Information System Market Competitive Landscape
The Cardiovascular Information System market is classified as Moderately Concentrated. A group of large, diversified medical technology companies with broad enterprise imaging portfolios, including GE HealthCare, Koninklijke Philips, Siemens Healthineers, Fujifilm, and Canon Medical Systems, anchor the top tier through integrated imaging hardware and software ecosystems, while specialized cardiovascular and enterprise imaging vendors such as Agfa HealthCare, INFINITT Healthcare, Sectra, Merative, and Digisonics compete through deep cardiology-specific functionality, high customer satisfaction, and strong EHR integration, increasing competition across both large hospital networks and specialty cardiology centers.
The competitive landscape can be evaluated across the following dimensions:
- Market concentration: Moderately concentrated, with diversified imaging conglomerates leading and a strong field of specialized cardiovascular and enterprise imaging vendors.
- Leading players: GE HealthCare, Koninklijke Philips, and Siemens Healthineers anchor the top tier through integrated imaging hardware, software, and global service networks.
- Geographic reach: Leaders operate global, multi-region deployments; Sectra alone manages 170 million annual imaging exams worldwide and holds Best in KLAS rankings across North America, Europe, the Middle East/Africa, and Oceania.
- Service portfolio strength: Top players offer end-to-end structured reporting, image management, hemodynamic monitoring, AI-enabled analytics, and cloud hosting.
- Customer satisfaction and recognition: Best in KLAS rankings are a decisive competitive signal; INFINITT Cardiology Suite ranked Best in KLAS for CVIS products in 2026, while Merge by Merative's Merge Hemo retained its Best in KLAS ranking for hemodynamic systems.
- Strategic partnerships: Tie-ups extending platform reach, such as GE HealthCare and AliveCor's integration between the MUSE Cardiology Information System and AliveCor's ECG technology, and Philips' January 2026 telehealth partnership for remote cardiovascular monitoring.
- M&A and technology acquisition activity: Active consolidation around AI capability, including Sectra's 2026 acquisition of autonomous AI diagnostics company Oxipit.
- Cloud and deployment capabilities: FDA clearances for cloud-hosted platforms, including Philips' Cardiovascular Workspace and Sectra One Cloud, are becoming key competitive differentiators.
- Innovation focus: AI-enabled structured reporting, cloud-native architecture, enterprise imaging consolidation, and remote monitoring integration.
Cardiovascular Information System Market Recent Developmental Activities
In 2026, Sectra AB completed its acquisition of Oxipit, an autonomous AI diagnostics company, advancing AI capabilities across its enterprise and cardiovascular imaging portfolio. Strategic significance: Strengthens Sectra's AI-enabled reporting capability and reinforces its position as a top-rated enterprise and cardiology imaging vendor.
In July 2026, Sectra AB was selected by Hennick Humber Hospital in Canada to provide its fully managed cloud enterprise imaging solution, Sectra One Cloud. Strategic significance: Extends Sectra's cloud deployment footprint and demonstrates growing hospital demand for managed cloud enterprise imaging.
Cardiovascular Information System Market Segmentation
Cardiovascular Information System Market by System Type
- Cardiovascular Information System (CVIS)
- Cardiovascular Picture Archiving and Communication System (CPACS)
Cardiovascular Information System Market by Component
- Software
- Services
Cardiovascular Information System Market by Deployment
- On-Premise
- Cloud-Based
- Hybrid
Cardiovascular Information System Market by End-Users
- Hospitals
- Diagnostic Centers
- Specialty Cardiology Centers
- Others
Cardiovascular Information System Market by Geography
- North America Cardiovascular Information System Market
- United States Cardiovascular Information System Market Size in USD million (2023-2034)
- Canada Cardiovascular Information System Market Size in USD million (2023-2034)
- Mexico Cardiovascular Information System Market Size in USD million (2023-2034)
- Europe Cardiovascular Information System Market
- Germany Cardiovascular Information System Market Size in USD million (2023-2034)
- United Kingdom Cardiovascular Information System Market Size in USD million (2023-2034)
- France Cardiovascular Information System Market Size in USD million (2023-2034)
- Italy Cardiovascular Information System Market Size in USD million (2023-2034)
- Spain Cardiovascular Information System Market Size in USD million (2023-2034)
- Rest of Europe Cardiovascular Information System Market Size in USD million (2023-2034)
- Asia-Pacific Cardiovascular Information System Market
- China Cardiovascular Information System Market Size in USD million (2023-2034)
- Japan Cardiovascular Information System Market Size in USD million (2023-2034)
- India Cardiovascular Information System Market Size in USD million (2023-2034)
- Australia Cardiovascular Information System Market Size in USD million (2023-2034)
- South Korea Cardiovascular Information System Market Size in USD million (2023-2034)
- Rest of Asia-Pacific Cardiovascular Information System Market Size in USD million (2023-2034)
- Rest of the World (RoW) Cardiovascular Information System Market
- Middle East Cardiovascular Information System Market Size in USD million (2023-2034)
- Africa Cardiovascular Information System Market Size in USD million (2023-2034)
- South America Cardiovascular Information System Market Size in USD million (2023-2034)
Key Takeaways from the Cardiovascular Information System Market Report Study
- Market size analysis for the current Cardiovascular Information System market size (2025), and market forecast for 9 years (2026 to 2034).
- Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
- Key companies dominating the global Cardiovascular Information System market.
- Various opportunities available for competitors in the Cardiovascular Information System market space.
- What are the top-performing segments in 2025? How will these segments perform in 2034?
- Which are the top-performing regions and countries in the current Cardiovascular Information System market scenario?
- Which are the regions and countries where companies should concentrate their opportunities for Cardiovascular Information System market growth in the future?
Target audience who can benefit from this Cardiovascular Information System market report study
- Cardiovascular Information System product providers
- Research organizations and consulting companies
- Cardiovascular Information System -related organizations, associations, forums, and other alliances
- Government and corporate offices
- Start-up companies, venture capitalists, and private equity firms
- Distributors and traders dealing in Cardiovascular Information System
- Various end-users who want to know more about the Cardiovascular Information System market and the latest technological developments in the Cardiovascular Information System market.
Frequently Asked Questions:
Q1. What is the growth rate of the Cardiovascular Information System market?
The Cardiovascular Information System market is projected to expand at a CAGR of 9.2% during the forecast period from 2026 to 2034.
Q2. What is the market size of the Cardiovascular Information System market?
The Cardiovascular Information System market is estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.98 billion by 2034.
Q3. Which region dominates the Cardiovascular Information System market?
North America dominated the Cardiovascular Information System market with a 46% share of global revenue in 2025, supported by a mature cardiology IT ecosystem, high cardiovascular disease burden, deep EHR penetration, FDA regulatory clarity for cloud-enabled platforms, and the highest concentration of Best in KLAS-ranked vendors. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the Cardiovascular Information System market?
The principal drivers are the rising global burden of cardiovascular disease; the accelerating shift to cloud-hosted and software-as-a-service cardiology platforms, exemplified by Philips' November 2025 FDA clearance for a cloud-enabled Cardiovascular Workspace; growing integration of artificial intelligence into cardiology reporting and analytics; increasing interoperability requirements between cardiovascular information systems, electronic health records, and cath lab systems; and expanding remote monitoring and preventive cardiology integration.
Q5. Who are the major players in the Cardiovascular Information System market?
The major players include GE HealthCare, Koninklijke Philips N.V., Siemens Healthineers AG, Fujifilm Holdings Corporation, Agfa HealthCare, INFINITT Healthcare Co., Ltd., Sectra AB, Canon Medical Systems Corporation, Merative L.P., and Digisonics, Inc., among other active providers profiled in the Competitive Landscape section. GE HealthCare, Koninklijke Philips, and Siemens Healthineers lead through integrated imaging hardware, software, and global service networks.
Table of Contents
1. Cardiovascular Information System Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumptions
2. Cardiovascular Information System Market Executive Summary
- 2.1 Market at a Glance
3. Cardiovascular Information System Market Key Factors Analysis
- 3.1 Cardiovascular Information System Market Drivers
- 3.1.1 Rising Global Burden of Cardiovascular Disease
- 3.1.2 Shift to Cloud-Hosted and SaaS Platforms
- 3.1.3 Integration of Artificial Intelligence into Cardiology Workflows
- 3.1.4 Interoperability and Enterprise Imaging Consolidation
- 3.2 Cardiovascular Information System Market Restraints and Challenges
- 3.2.1 High Implementation and Maintenance Costs
- 3.2.2 Integration Complexity Across Cardiology Devices
- 3.2.3 Workforce, Security, and Infrastructure Constraints
- 3.3 Cardiovascular Information System Market Opportunities
- 3.3.1 Cloud Migration and AI-Enabled Reporting Expansion
- 3.3.2 Emerging-Market and Remote Monitoring Expansion
4. Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
5. Regulatory Analysis
- 5.1 United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
6. Cardiovascular Information System Market Porter's Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Buyers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
7. Cardiovascular Information System Market Assessment
- 7.1 By System Type
- 7.1.1 Cardiovascular Information System (CVIS)
- 7.1.2 Cardiovascular Picture Archiving and Communication System (CPACS)
- 7.2 By Component
- 7.2.1 Software
- 7.2.2 Services
- 7.3 By Deployment
- 7.3.1 On-Premise
- 7.3.2 Cloud-Based
- 7.3.3 Hybrid
- 7.4 By End-Users
- 7.4.1 Hospitals
- 7.4.2 Diagnostic Centers
- 7.4.3 Specialty Cardiology Centers
- 7.4.4 Others
- 7.5 By Geography
- 7.5.1 North America
- 7.5.1.1 United States Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.1.2 Canada Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.1.3 Mexico Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.2 Europe
- 7.5.2.1 Germany Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.2.2 United Kingdom Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.2.3 France Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.2.4 Italy Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.2.5 Spain Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.2.6 Rest of Europe Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.3 Asia-Pacific
- 7.5.3.1 China Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.3.2 Japan Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.3.3 India Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.3.4 Australia Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.3.5 South Korea Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.3.6 Rest of Asia-Pacific Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.4 Rest of World
- 7.5.4.1 Middle East Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.4.2 Africa Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.4.3 South America Cardiovascular Information System Market Size in USD million (2023-2034)
- 7.5.1 North America
8. Cardiovascular Information System Market Competitive Landscape
- 8.1 Market Concentration and Structure
- 8.2 Competitive Positioning and Market Share Analysis (Premium Offering)
9. Cardiovascular Information System Market Startup Funding and Investment Trends
10. Cardiovascular Information System Market Company and Product Profiles
- 10.1 GE HealthCare
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Service Portfolio
- 10.1.5 Strategic Initiatives / Entropy
- 10.2 Koninklijke Philips N.V
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Portfolio
- 10.2.5 Strategic Initiatives / Entropy
- 10.3 Siemens Healthineers AG
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Portfolio
- 10.3.5 Strategic Initiatives / Entropy
- 10.4 Fujifilm Holdings Corporation
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Portfolio
- 10.4.5 Strategic Initiatives / Entropy
- 10.5 Agfa HealthCare
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Portfolio
- 10.5.5 Strategic Initiatives / Entropy
- 10.6 INFINITT Healthcare Co., Ltd.
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Portfolio
- 10.6.5 Strategic Initiatives / Entropy
- 10.7 Sectra AB
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Portfolio
- 10.7.5 Strategic Initiatives / Entropy
- 10.8 Canon Medical Systems Corporation
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Portfolio
- 10.8.5 Strategic Initiatives / Entropy
- 10.9 Merative L.P
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Portfolio
- 10.9.5 Strategic Initiatives / Entropy
- 10.10 Digisonics, Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Portfolio
- 10.10.5 Strategic Initiatives / Entropy
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.
